首页> 外文OA文献 >Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial

【2h】

Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial

机译：吉列法妥和基于铂金疗法失败的Regorafenib用于局部晚期/转移性胆汁肿瘤：到达，随机，双盲，II期试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
A. Demols; I. Borbath; M. Van den Eynde; G. Houbiers; M. Peeters; R. Marechal; T. Delaunoit; J.-C. Goemine; S. Laurent; S. Holbrechts; M. Paesmans; J.-L. Van Laethem;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. CMAB009联合伊立替康或伊立替康单药二线治疗氟嘧啶和奥沙利铂治疗失败的KRAS野生型转移性结直肠癌患者的研究:一项前瞻性、开放、随机、Ⅲ期试验 [J] . 石远凯, 白丽, 张沂平, 癌症（英文版） . 2020,第007期
3. Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05) [J] . KregeS., RexerH., VomDorpF., BJU international . 2014,第3期

机译：前瞻性随机双盲多中心II期研究比较吉西他滨和顺铂加索拉非尼化疗与吉西他滨和顺铂加安慰剂治疗局部晚期和/或转移性尿路上皮癌：SUSE（AUO-AB 31/05）
4. Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial [J] . Middleton Gary, Palmer Daniel H., Greenhalf William, The lancet oncology . 2017,第4期

机译：Vandetanib Plus Gemcitabine与安慰剂加上吉西他滨，在本地先进或转移性胰腺癌（VIP）：一项潜在，随机，双盲，多元相2试验
5. Possibility of immunotherapy for biliary tract cancer: how do we prove efficacy? Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to gemcitabine and cisplatin for the treatment of advanced biliary tract cancer (WT-BT trial). [J] . Takuji Okusaka, Makoto Ueno, Tosiya Sato, Journal of hepato-biliary-pancreatic sciences . 2012,第4期

机译：胆道癌免疫治疗的可能性：我们如何证明疗效？介绍当前正在进行的I期和II期随机研究，以评估在吉西他滨和顺铂中添加Wilms肿瘤1肽疫苗治疗晚期胆道癌的有效性和安全性（WT-BT试验）。
6. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
7. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
8. Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID a randomized double-blind placebo-controlled phase III study of regorafenib versus placebo [O] . Chris D. Poole, Mark P. Connolly, Jane Chang, -1

机译：伊马替尼和舒尼替尼治疗失败后晚期胃肠道间质瘤（GIST）患者的健康效用：来自GRID的结果一项随机双盲安慰剂对照的regorafenib与安慰剂对照的III期研究
9. Exploratory analysis based on tumor location of REACHIN, a randomized, double-blinded, placebo-controlled phase 2 trial of regorafenib after failure of gemcitabine and platinum-based chemotherapy for advanced/metastatic biliary tract tumors [O] . A. Demols, I. Borbath, M. Van den Eynde, 2019

机译：基于肿瘤位置的探索性分析，在吉西他滨和铂类化疗失败后，吉西他滨和铂胆道肿瘤失败后的可随机，双盲，安慰剂控制相2试验

Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial

著录项

引文网络

相似文献

相关主题

期刊订阅